Evidence map›Paper›PMID 29070671›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.

Sarah J Kane, Taylor K Farley, Elizabeth O Gordon, Joshua Estep, Heather R Bender, Julie A Moreno, Jason Bartz, Glenn C Telling, Matthew C Pickering, Mark D Zabel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Innate Immune Mechanisms in the Central Nervous System.Advances in experimental medicine and biology · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Exosome-enriched fractions from MS B cells induce oligodendrocyte death.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Article
  8. How do PrPPathogens (Basel, Switzerland) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Sarah J KanePrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.ORCID 0000-0002-6072-5682
Taylor K FarleyPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Elizabeth O GordonPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Joshua EstepPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Heather R BenderPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Julie A MorenoPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Jason BartzSchool of Medicine, Creighton University, Omaha, NE 68178; and.
Glenn C TellingPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.
Matthew C PickeringDepartment of Medicine, Centre for Complement and Inflammation Research, Imperial College, London W12 0NN, United Kingdom.ORCID 0000-0002-1153-0192
Mark D ZabelPrion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523; Mark.Zabel@colostate.edu.ORCID 0000-0002-2666-9197
Colorado State University · USCentre for Inflammation Research · GBCreighton University · USNational Institutes of Health · US

Funding

Key molecular mechanisms of extraneural pathogenesis and transmission of TSEsR01NS056379 · NINDS · COLORADO STATE UNIVERSITY · PI ZABEL, MARK D · 2008 to 2012
$1.4M
Key Molecular Mechanisms of TSEsR56AI122273 · NIAID · COLORADO STATE UNIVERSITY · PI ZABEL, MARK D · 2016 to 2016
$372k
Molecular Mechanisms of Peripheral Prion PathogenesisF31NS087762 · NINDS · COLORADO STATE UNIVERSITY · PI KANE, SARAH JO · 2014 to 2016
$102k
NIAID NIH HHS R56 AI122273NINDS NIH HHS F31 NS087762NINDS NIH HHS R01 NS056379
6 · The paper itself

Abstract

Several complement proteins exacerbate prion disease, including C3, C1q, and CD21/35. These proteins of the complement cascade likely increase uptake, trafficking, and retention of prions in the lymphoreticular system, hallmark sites of early prion propagation. Complement regulatory protein factor H (fH) binds modified host proteins and lipids to prevent C3b deposition and, thus, autoimmune cell lysis. Previous reports show that fH binds various conformations of the cellular prion protein, leading us to question the role of fH in prion disease. In this article, we report that transgenic mice lacking

Indexed as

AnimalsB-LymphocytesBrainCells, CulturedComplement Factor HComplement Inactivating AgentsComplement Pathway, AlternativeDendritic CellsMacrophagesMiceMice, Inbred C57BLMice, KnockoutPrion DiseasesPrionsProtein BindingComplement Factor HComplement Inactivating AgentsPrions

Identifiers

PMID29070671
PMCPMC5698161
OpenAlexW2765730989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.